CSIMarket Company Name, Ticker, Customers, else..
 
Apogee Therapeutics Inc   (NASDAQ: APGE)
 

Apogee Therapeutics Inc's Suppliers Performance

APGE's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
APGE Costs vs Sales of Suppliers Growth

• More on APGE Suppliers






Apogee Therapeutics Inc's Comment on Supply Chain


The company utilizes raw materials to manufacture its product candidates, including zumilokibart, APG990, APG333, and APG808. It maintains or plans to maintain sufficient manufacturing capacity and clinical supply to support its clinical trials. To address supply chain risks, particularly in relation to the BIOSECURE Act, the company is identifying and selecting additional suppliers based in the U.S. and EU for contract development, manufacturing, testing, and storage. It monitors geopolitical risks and implements mitigation strategies and redundancies as necessary. Key suppliers include WuXi Biologics and Samsung Biologics.

Apogee Therapeutics Inc's Comment on Supply Chain


The company utilizes raw materials to manufacture its product candidates, including zumilokibart, APG990, APG333, and APG808. It maintains or plans to maintain sufficient manufacturing capacity and clinical supply to support its clinical trials. To address supply chain risks, particularly in relation to the BIOSECURE Act, the company is identifying and selecting additional suppliers based in the U.S. and EU for contract development, manufacturing, testing, and storage. It monitors geopolitical risks and implements mitigation strategies and redundancies as necessary. Key suppliers include WuXi Biologics and Samsung Biologics.







APGE's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Apogee Therapeutics Inc 10,190.15 0.00 -294.37 261
SUBTOTAL 0.00 0.00 0.00 -


Sources: Apogee Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Apogee Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.